Molnupiravir not of much benefit, won’t keep it in protocol, says ICMR task force

The ICMR’s national task force for Covid-19 has decided against including antiviral drug molnupiravir in the clinical management protocol for Covid as of now, official sources said on Tuesday.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3FjYX5u